JP2013100370A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013100370A5 JP2013100370A5 JP2013040387A JP2013040387A JP2013100370A5 JP 2013100370 A5 JP2013100370 A5 JP 2013100370A5 JP 2013040387 A JP2013040387 A JP 2013040387A JP 2013040387 A JP2013040387 A JP 2013040387A JP 2013100370 A5 JP2013100370 A5 JP 2013100370A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancer cells
- cancer
- cancer cell
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80364006P | 2006-06-01 | 2006-06-01 | |
| US60/803,640 | 2006-06-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Division JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014248831A Division JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013100370A JP2013100370A (ja) | 2013-05-23 |
| JP2013100370A5 true JP2013100370A5 (cg-RX-API-DMAC7.html) | 2013-11-07 |
| JP5665899B2 JP5665899B2 (ja) | 2015-02-04 |
Family
ID=38802246
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2014248831A Pending JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014248831A Pending JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8512713B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP2021023A4 (cg-RX-API-DMAC7.html) |
| JP (4) | JP2009538935A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090014364A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101460194B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007256754B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2951453A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL195297A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008015265A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ572893A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007143548A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200809769B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ572893A (en) | 2006-06-01 | 2011-06-30 | Robarts Res Inst | Myxoma virus mutants for cancer treatment |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| WO2019227022A1 (en) | 2018-05-25 | 2019-11-28 | Bioventures, Llc | Myxoma virus compositions and methods of use |
| EP3846829A4 (en) * | 2018-09-05 | 2022-09-14 | Arizona Board of Regents on behalf of Arizona State University | ONCOLYTIC VIRUS PLATFORM FOR THE TREATMENT OF HEMATOLOGICAL CANCER |
| WO2020106880A1 (en) | 2018-11-20 | 2020-05-28 | Bioventures, Llc | Cells for the production of viruses and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0003911A3 (en) | 1997-10-09 | 2007-11-28 | Pro Virus | Treatment of neoplasms with viruses |
| ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| MXPA01010393A (es) | 1999-04-15 | 2004-04-02 | Pro Virus Inc | Tratamiento de neoplasmas con virus. |
| EP1200595A2 (en) | 1999-07-12 | 2002-05-02 | Viron Therapeutics, Inc. | Myxoma virus genes for immune modulation |
| WO2001087324A1 (en) | 2000-05-17 | 2001-11-22 | Viron Therapeutics, Inc. | Compositions and methods for promoting immunosuppression |
| US6942864B2 (en) * | 2001-03-08 | 2005-09-13 | Akzo Nobel N.V. | Leporipox-based vector vaccines |
| JP4800924B2 (ja) * | 2003-03-07 | 2011-10-26 | ロバーツ リサーチ インスティテュート | 癌および慢性ウイルス感染の治療処置のための粘液腫症ウイルスの使用 |
| NZ550430A (en) | 2004-04-27 | 2009-06-26 | Wellstat Biologics Corp | Cancer treatment using viruses and camptothecins |
| CN102357104B (zh) * | 2005-03-07 | 2016-01-27 | 罗巴斯研究机构 | 粘液瘤病毒与雷帕霉素的组合在治疗性处理中的应用 |
| NZ572893A (en) | 2006-06-01 | 2011-06-30 | Robarts Res Inst | Myxoma virus mutants for cancer treatment |
| WO2007143545A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| WO2007147118A1 (en) | 2006-06-16 | 2007-12-21 | Robarts Research Institute | Infection of cells with myxoma virus requires akt activation |
-
2007
- 2007-06-01 NZ NZ572893A patent/NZ572893A/en not_active IP Right Cessation
- 2007-06-01 EP EP07798014A patent/EP2021023A4/en not_active Withdrawn
- 2007-06-01 CA CA2951453A patent/CA2951453A1/en not_active Abandoned
- 2007-06-01 US US12/301,961 patent/US8512713B2/en not_active Expired - Fee Related
- 2007-06-01 JP JP2009513472A patent/JP2009538935A/ja not_active Withdrawn
- 2007-06-01 KR KR1020087029274A patent/KR20090014364A/ko not_active Ceased
- 2007-06-01 EP EP17182211.7A patent/EP3254694A1/en not_active Withdrawn
- 2007-06-01 EP EP11184754.7A patent/EP2457584B1/en not_active Not-in-force
- 2007-06-01 CN CN2007800202887A patent/CN101460194B/zh not_active Expired - Fee Related
- 2007-06-01 MX MX2008015265A patent/MX2008015265A/es active IP Right Grant
- 2007-06-01 CA CA2652228A patent/CA2652228C/en not_active Expired - Fee Related
- 2007-06-01 WO PCT/US2007/070219 patent/WO2007143548A2/en not_active Ceased
- 2007-06-01 AU AU2007256754A patent/AU2007256754B2/en not_active Ceased
-
2008
- 2008-11-13 ZA ZA200809769A patent/ZA200809769B/xx unknown
- 2008-11-13 IL IL195297A patent/IL195297A/en active IP Right Grant
-
2013
- 2013-03-01 JP JP2013040387A patent/JP5665899B2/ja not_active Expired - Fee Related
- 2013-08-19 US US13/969,853 patent/US20130336930A1/en not_active Abandoned
-
2014
- 2014-12-09 JP JP2014248831A patent/JP2015044878A/ja active Pending
-
2016
- 2016-01-21 US US15/002,971 patent/US9980994B2/en active Active
- 2016-10-06 JP JP2016197808A patent/JP2017008105A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287381A (en) | Pharmaceutical preparations of human rpe cells and uses thereof | |
| MX2022006107A (es) | Metodos y composiciones para dosificacion en terapia celular adoptiva. | |
| IL239923A0 (en) | Solid solution compositions and use in cardiovascular disease | |
| CL2014002757A1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer. | |
| CL2014001792A1 (es) | Compuestos derivados de carbamato; composicion farmaceutica, y uso de los mismos en el tratamiento del dolor, cancer por tumor solido, obesidad, entre otras enfermedades. | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| JP2014141525A5 (cg-RX-API-DMAC7.html) | ||
| EA201690093A1 (ru) | Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний | |
| WO2015031771A3 (en) | Administration of kynurenine depleting enzymes for tumor therapy | |
| EA202090662A3 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ | |
| PH12015502539B1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| TN2012000335A1 (en) | Antibody formulation and therapeutic regimens | |
| HUE036220T2 (hu) | Kinazolin származékok vírusfertõzések és további betegségek kezelésére | |
| EA201500314A1 (ru) | Лекарственные формы энзалутамида | |
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
| IL232325A0 (en) | 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease | |
| NZ606765A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| HUE046671T2 (hu) | Glutárimid származékokat tartalmazó gyógyászati készítmény, valamint ennek alkalmazása eozinofil betegségek kezelésében | |
| JP2013100370A5 (cg-RX-API-DMAC7.html) | ||
| SG11202103097QA (en) | Cancer therapy by combination use of oncolytic vaccinia virus and immune checkpoint inhibitor, and pharmaceutical composition and combination medicine for use in the cancer therapy | |
| JP2015044878A5 (cg-RX-API-DMAC7.html) | ||
| EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
| DK2802319T3 (da) | Fastdosiskombinationsterapi for parkinsons sygdom | |
| IL222343B (en) | Compositions comprising allogeneic th1 cells and inf-gamma for treating cancer or infectious diseases |